Latest period
$4.33B
YoY change
-26.1%
5Y CAGR
-16.7%
Peak year (2020)
$10.69B
Latest annual
$4.29B
Operating Cash Flow history chart for Elevance Health (ELV) from 2001 to 2025
Latest: $4.29B
Operating Cash Flow growth chart for Elevance Health (ELV) from 2001 to 2025
Latest: -26.1%
Operating Cash Flow history table for Elevance Health (ELV) from 2001 to 2025
| 2025 | $4.29B | -26.1% | −$1.52B | ||
| 2024 | $5.81B | -27.9% | −$2.25B | ||
| 2023 | $8.06B | -4.0% | −$338.00M | ||
| 2022 | $8.40B | +0.4% | +$35.00M | ||
| 2021 | $8.36B | -21.7% | −$2.32B | ||
| 2020 | $10.69B | +76.3% | +$4.63B | ||
| 2019 | $6.06B | +58.4% | +$2.23B | ||
| 2018 | $3.83B | -8.5% | −$357.80M | ||
| 2017 | $4.18B | +30.6% | +$980.30M | ||
| 2016 | $3.20B | -22.1% | −$911.50M | ||
| 2015 | $4.12B | +22.2% | +$746.70M | ||
| 2014 | $3.37B | +10.4% | +$317.00M | ||
| 2013 | $3.05B | +11.2% | +$307.70M | ||
| 2012 | $2.74B | -18.7% | −$629.80M | ||
| 2011 | $3.37B | +138.2% | +$1.96B | ||
| 2010 | $1.42B | -53.4% | −$1.62B | ||
| 2009 | $3.04B | +19.9% | +$503.50M | ||
| 2008 | $2.54B | -41.6% | −$1.81B | ||
| 2007 | $4.34B | +7.4% | +$300.40M | ||
| 2006 | $4.04B | +24.2% | +$787.50M | ||
| 2005 | $3.26B | +149.9% | +$1.95B | ||
| 2004 | $1.30B | +14.0% | +$159.80M | ||
| 2003 | $1.14B | +15.4% | +$152.30M | ||
| 2002 | $991.10M | +51.4% | +$336.50M | ||
| 2001 | $654.60M | — | — |
- 2025$4.29B-26.1%
- 2024$5.81B-27.9%
- 2023$8.06B-4.0%
- 2022$8.40B+0.4%
- 2021$8.36B-21.7%
- 2020$10.69B+76.3%
- 2019$6.06B+58.4%
- 2018$3.83B-8.5%
- 2017$4.18B+30.6%
- 2016$3.20B-22.1%
- 2015$4.12B+22.2%
- 2014$3.37B+10.4%
- 2013$3.05B+11.2%
- 2012$2.74B-18.7%
- 2011$3.37B+138.2%
- 2010$1.42B-53.4%
- 2009$3.04B+19.9%
- 2008$2.54B-41.6%
- 2007$4.34B+7.4%
- 2006$4.04B+24.2%
- 2005$3.26B+149.9%
- 2004$1.30B+14.0%
- 2003$1.14B+15.4%
- 2002$991.10M+51.4%
- 2001$654.60M—
Operating Cash Flow values are taken from Elevance Health's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Cash Flow at Elevance Health (ELV)
Operating Cash Flow for Elevance Health (ELV): headline value $4.33B · YoY -26.1%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual operating cash flow for Elevance Health (ELV) came in at $4.29B – declined 26.1% year-over-year.
Across 2020–2025 (5 years), Elevance Health operating cash flow produced a CAGR of -16.7% – with a net decline across the window.
Between 2020 and 2025, Elevance Health operating cash flow plunged 59.9%, falling from $10.69B to $4.29B.
2020 marks the peak operating cash flow at $10.69B, with the historical low of $654.60M recorded in 2001.
Elevance Health Operating Cash Flow by Year
Elevance Health Operating Cash Flow 2025: $4.29B
Elevance Health operating cash flow in 2025 was $4.29B, declined 26.1% below 2024.
Elevance Health Operating Cash Flow 2024: $5.81B
2024's operating cash flow for Elevance Health came in at $5.81B, declined 27.9% below 2023.
Elevance Health Operating Cash Flow 2023: $8.06B
Elevance Health posted operating cash flow of $8.06B in 2023, edged down 4.0% below 2022.
Elevance Health Operating Cash Flow 2022: $8.40B
In 2022, Elevance Health reported operating cash flow of $8.40B, edged up 0.4% from 2021.
Elevance Health Operating Cash Flow 2021: $8.36B
Elevance Health operating cash flow in 2021 was $8.36B.
See more financial history for Elevance Health (ELV).
Sector peers by Operating Cash Flow
Healthcare peers of Elevance Health (ELV), ranked by their latest operating cash flow
| $24.53B | |
| $19.70B | |
| $19.03B | |
| $18.56B | |
| $16.81B | |
| $16.47B | |
| $14.57B | |
| $9.96B |
- $24.53B
- $19.70B
- $19.03B
- $18.56B
- $16.81B
- $16.47B
- $14.57B
- $9.96B
Frequently asked questions
Elevance Health (ELV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation